Segmentectomy or Lobectomy for Early-Stage Lung Cancer? A Patient-Centered Framework for Surgical Decision-Making

Randomized trials have established segmentectomy and sublobar resection as oncologically appropriate alternatives to lobectomy for selected patients with small, peripheral, node-negative non-small cell lung cancer (NSCLC). These findings have expanded surgical options but also shifted the clinical question from whether sublobar resection is adequate to how the extent of resection should be individualized. Patients considering lung cancer surgery want to know: What provides the best chance of cure? How safe is the operation? How will surgery affect breathing and quality of life? What will recovery look like? And which operation is right for them? These questions provide the framework for this review. We examine the evidence needed to address each question, including oncologic outcomes and recurrence, tumor location and achievable margins, lymph node assessment, radiographic and biologic tumor characteristics, perioperative outcomes, preservation of pulmonary function, quality of life, and postoperative recovery. Long-term considerations include competing risks of mortality, the development of second primary lung cancers, and preservation of treatment options for future lung disease. The relative importance of these factors differs among patients and may alter the balance between oncologic control and parenchymal preservation. This review provides a patient-centered framework for integrating tumor characteristics, operative considerations, functional outcomes, and patient factors to individualize the choice between segmentectomy and lobectomy for early-stage NSCLC.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-17
DOI
https://doi.org/10.3390/cancers18223670
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Segmentectomy or Lobectomy for Early-Stage Lung Cancer? A Patient-Centered Framework for Surgical Decision-Making

Shachi Srivatsa, Peter J. Kneuertz
Cancers
Lung Cancer Diagnosis and Treatment
article

Segmentectomy or Lobectomy for Early-Stage Lung Cancer? A Patient-Centered Framework for Surgical Decision-Making

Shachi Srivatsa, Peter J. Kneuertz
article en

Abstract

Randomized trials have established segmentectomy and sublobar resection as oncologically appropriate alternatives to lobectomy for selected patients with small, peripheral, node-negative non-small cell lung cancer (NSCLC). These findings have expanded surgical options but also shifted the clinical question from whether sublobar resection is adequate to how the extent of resection should be individualized. Patients considering lung cancer surgery want to know: What provides the best chance of cure? How safe is the operation? How will surgery affect breathing and quality of life? What will recovery look like? And which operation is right for them? These questions provide the framework for this review. We examine the evidence needed to address each question, including oncologic outcomes and recurrence, tumor location and achievable margins, lymph node assessment, radiographic and biologic tumor characteristics, perioperative outcomes, preservation of pulmonary function, quality of life, and postoperative recovery. Long-term considerations include competing risks of mortality, the development of second primary lung cancers, and preservation of treatment options for future lung disease. The relative importance of these factors differs among patients and may alter the balance between oncologic control and parenchymal preservation. This review provides a patient-centered framework for integrating tumor characteristics, operative considerations, functional outcomes, and patient factors to individualize the choice between segmentectomy and lobectomy for early-stage NSCLC.

CancersVol. 18(22)
The Ohio State University Wexner Medical Center (US)
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon